Cystatin C may be better than creatinine for digoxin dosing in older adults with atrial fibrillation

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F27661989%3A_____%2F20%3AN0000005" target="_blank" >RIV/27661989:_____/20:N0000005 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/61988987:17110/20:A21025ZB

Výsledek na webu

<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/jcla.23427" target="_blank" >https://onlinelibrary.wiley.com/doi/full/10.1002/jcla.23427</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1002/jcla.23427" target="_blank" >10.1002/jcla.23427</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Cystatin C may be better than creatinine for digoxin dosing in older adults with atrial fibrillation

Popis výsledku v původním jazyce

Background Patients taking digoxin are older with high probability of having low muscle mass, and current clinical practice in digoxin dosing relies only on estimated glomerular filtration rate from serum creatinine (eGFRcrea). The aim of the study is to compare eGFRcrea and estimated glomerular filtration rate from serum cystatin C (eGFRcys) in older adult patients with atrial fibrillation (AF) overdosed with digoxin. Methods A total of 80 consecutive patients overdosed with digoxin and 33 controls with AF from Department of Internal Medicine were included in the prospective observational study. The median of age of participants was 81 years in both the overdosed and the control group. The eGFRs were calculated using The Chronic Kidney Disease Epidemiology (CKD- EPI) equations using standardized methods for serum creatinine and cystatin C measurement. Results The median (IQR) of eGFRcrea was higher than that of eGFRcys (45 mL/min/1.73 m(2)(35-59) vs 30 (21-38), respectively;P < .0001) in overdosed patients. The median (IQR) of eGFRcrea was higher than that of eGFRcys (61 mL/min/1.73 m(2)(49-72) vs 40 (30-56), respectively;P < .0001) in control group of patients. Serum predose digoxin concentration in overdosed patients was inversely associated with eGFRcys (rho = -0.26,P < .05). Conclusion Physicians should consider GFR when changing digoxin dosing. eGFRcys was lower in both the overdosed and the control group. eGFRcys would lead to lower digoxin doses and thus prevent overdose.

Název v anglickém jazyce

Cystatin C may be better than creatinine for digoxin dosing in older adults with atrial fibrillation

Popis výsledku anglicky

Background Patients taking digoxin are older with high probability of having low muscle mass, and current clinical practice in digoxin dosing relies only on estimated glomerular filtration rate from serum creatinine (eGFRcrea). The aim of the study is to compare eGFRcrea and estimated glomerular filtration rate from serum cystatin C (eGFRcys) in older adult patients with atrial fibrillation (AF) overdosed with digoxin. Methods A total of 80 consecutive patients overdosed with digoxin and 33 controls with AF from Department of Internal Medicine were included in the prospective observational study. The median of age of participants was 81 years in both the overdosed and the control group. The eGFRs were calculated using The Chronic Kidney Disease Epidemiology (CKD- EPI) equations using standardized methods for serum creatinine and cystatin C measurement. Results The median (IQR) of eGFRcrea was higher than that of eGFRcys (45 mL/min/1.73 m(2)(35-59) vs 30 (21-38), respectively;P < .0001) in overdosed patients. The median (IQR) of eGFRcrea was higher than that of eGFRcys (61 mL/min/1.73 m(2)(49-72) vs 40 (30-56), respectively;P < .0001) in control group of patients. Serum predose digoxin concentration in overdosed patients was inversely associated with eGFRcys (rho = -0.26,P < .05). Conclusion Physicians should consider GFR when changing digoxin dosing. eGFRcys was lower in both the overdosed and the control group. eGFRcys would lead to lower digoxin doses and thus prevent overdose.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30200 - Clinical medicine

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of Clinical Laboratory Analysis

ISSN

0887-8013

e-ISSN

1098-2825

Svazek periodika

34

Číslo periodika v rámci svazku

10

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

5

Strana od-do

—

Kód UT WoS článku

000540617200001

EID výsledku v databázi Scopus

—